Home › NDC Lookup › RxCUI directory › RxCUI 360507

24 HR fluvastatin 80 MG Extended Release Oral Tablet — RxCUI 360507

RxNorm drug concept · Semantic clinical drug
RxCUI 360507 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI360507
Official name24 HR fluvastatin 80 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluvastatin sodium 80 MG 24HR Extended Release Oral Tablet; fluvastatin (as fluvastatin sodium) 80 MG 24 HR Extended Release Oral Tablet
FDA products mapped4
Package NDCs mapped7
Reported Medicaid activity (SDUD)38 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluvastatin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers cholesterol along with a healthy diet. It is also used in people with coronary heart disease to lower the chance of needing a procedure to open the heart arteries and to...
  • Take it by mouth, with or without food. Swallow capsules whole and do not open them. If you have the extended-release tablet, do not break, crush or chew it. Follow the schedule yo...
  • Headache, mild muscle aches, stomach upset, nausea, diarrhea and flu-like symptoms are the more common ones. Most are mild. Let me or your doctor know if they bother you.
  • Call promptly for unexplained muscle pain, tenderness or weakness, especially with fever. Also call for yellow skin or eyes, or signs of allergic reaction like swelling or trouble...
📖 Read our full Fluvastatin guide →

🕸️ Concept Web — How 24 HR fluvastatin 80 MG Extended Release Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR fluvastatin 80 MG Extended Release Oral Tablet RxCUI 360507

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fluvastatin 41127
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lescol 151972
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluvastatin Extended Release Oral Tablet 375074
    • Fluvastatin Oral Product 1165660
    • Fluvastatin Pill 1165661
    • Fluvastatin Extended Release Oral Tablet [Lescol] 687047
    • Lescol Oral Product 1166061
    • Lescol Pill 1166062
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluvastatin 80 MG SCDC · 330788
  • Fluvastatin Extended Release Oral Tablet SCDF · 375074
  • Fluvastatin Oral Product SCDG · 1165660
  • Fluvastatin Pill SCDG · 1165661

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 7 package NDCs
7 package NDCs map to RxCUI 360507 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-7446-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-... Fluvastatin Sodium Teva Pharmaceuticals USA, Inc. 2016-06-02
00093-7446-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-7... Fluvastatin Sodium Teva Pharmaceuticals USA, Inc. 2016-06-02
00527-2580-32 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... Fluvastatin Sodium Lannett Company, Inc. 2021-05-07
00527-2580-37 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... Fluvastatin Sodium Lannett Company, Inc. 2022-03-14
00781-8017-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0781-8017-01) FLUVASTATIN SODIUM ER Sandoz Inc 2018-05-02
00781-8017-31 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0781-8017-31) FLUVASTATIN SODIUM ER Sandoz Inc 2018-05-02
66758-0211-31 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (66758-211-31) Lescol XL Sandoz Inc 2024-08-02
Observed labelers: Sandoz Inc (3) · Lannett Company, Inc. (2) · Teva Pharmaceuticals USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.